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Summary
Enteropathogenic Escherichia coli (EPEC) strains
are diarrhoeal pathogens that use a type III secre-
tion system to translocate effector proteins into
host cells in order to colonize and multiply in the
human gut. Map, EspI and NleH1 are conserved
EPEC effectors that possess a C-terminal class I
PSD-95/Disc Large/ZO-1 (PDZ)-binding motif. Using
a PDZ array screen we identified Na+/H+ exchanger
regulatory factor 2 (NHERF2), a scaffold protein
involved in tethering and recycling ion channels in
polarized epithelia that contains two PDZ domains,
as a common target of Map, EspI and NleH1. Using
recombinant proteins and co-immunoprecipitation
we confirmed that NHERF2 binds each of the effec-
tors. We generated a HeLa cell line stably express-
ing HA-tagged NHERF2 and found that Map, EspI
and NleH1 colocalize and interact with intracellular
NHERF2 via their C-terminal PDZ-binding motif.
Overexpression of NHERF2 enhanced the forma-
tion and persistence of Map-induced filopodia,
accelerated the trafficking of EspI to the Golgi and
diminished the anti-apoptotic activity of NleH1. The
binding of multiple T3SS effectors to a single scaf-
fold protein is unique. Our data suggest that
NHERF2 may act as a plasma membrane sorting
site, providing a novel regulatory mechanism to
control the intracellular spatial and temporal effec-
tor protein activity.
Introduction
Enteropathogenic Escherichia coli (EPEC) strains are
Gram-negative pathogenic bacteria frequently associated
with infantile diarrhoea in non-industrial countries (Chen
and Frankel, 2005; Croxen and Finlay, 2010). During the
course of infection, EPEC adheres intimately to the
surface of enterocytes and provokes microvillus efface-
ment, leading to the formation of characteristic attaching
and effacing (A/E) lesions (Knutton et al., 1987). The
ability to form A/E lesions is associated with the LEE
pathogenicity island (McDaniel et al., 1995), which
encodes gene regulators, the adhesin intimin, a type III
secretion system (T3SS), chaperones and effector pro-
teins (Garmendia et al., 2005). In addition, EPEC strains
express a diverse number of non-LEE-encoded effectors
(Iguchi et al., 2009).cmi_1503 1718..1731
Following translocation, the effector proteins are tar-
geted to different cellular compartments and subvert
numerous cellular processes to sustain colonization and
multiplication (Garmendia et al., 2005). Map, EspI (also
known as NleA) and NleH1 are conserved effectors
and major EPEC virulence factors (Simpson et al., 2006;
Hemrajani et al., 2008; Lee et al., 2008). NleH1 inhibits
NF-kB-dependent transcription through an N-terminal
interaction with ribosomal protein S3 (RPS3) (Gao et al.,
2009) and prevents apoptosis through a C-terminal inter-
action with Bax inhibitor-1 (Hemrajani et al., 2010). EspI is
targeted to the Golgi apparatus where it interacts with the
Sec23/24 complex and inhibits COPII-mediated vesicular
transport between the endoplasmic reticulum and the
Golgi apparatus (Kim et al., 2007; Lee et al., 2008). As a
result, EspI contributes to the disruption of cellular tight
Received 18 May, 2010; revised 22 June, 2010; accepted 28 June,
2010. *For correspondence. E-mail g.frankel@imperial.ac.uk; Tel.
+44 20 7594 5253; Fax +44 20 7594 3069.
Re-use of this article is permitted in accordance with the Terms
and Conditions set out at http://wileyonlinelibrary.com/onlineopen#
OnlineOpen_Terms
Cellular Microbiology (2010) 12(12), 1718–1731 doi:10.1111/j.1462-5822.2010.01503.x
First published online 3 August 2010
© 2010 Blackwell Publishing Ltd
cellular microbiology
junctions (Thanabalasuriar et al., 2010). Map is targeted
to the mitochondria via an N-terminal mitochondrial
targeting sequence where it disrupts the mitochondrial
membrane potential (Kenny and Jepson, 2000;
Papatheodorou et al., 2006). At early time points Map
induces formation of transient filopodia at the bacterial
attachment sites (Kenny and Jepson, 2000) via its guanine
exchange factor (GEF) activity for the Rho-GTPase Cdc42
(Huang et al., 2009). Moreover, via its C-terminus, which
comprises a class I PSD-95/Disc Large/ZO-1 (PDZ)-
binding motif (TRL), Map binds PDZ 1 of Na+/H+ exchanger
regulatory factor 1 (NHERF1) (Alto et al., 2006; Simpson
et al., 2006). PDZ domains are protein–protein recognition
domains of about 90 amino acids, which are widely repre-
sented in the human genome (Tonikian et al., 2008). PDZ-
binding motifs comprise a consensus S/T-X-F sequence
(where X is any amino acid and F is any hydrophobic
residues (Songyang et al., 1997). Importantly, PDZ binding
motifs are also found at the C-termini of NleH1 and EspI
(SKI and TRV respectively). Whereas no mammalian
partner was thus far associated with the PDZ-binding motif
of NleH1, a previous report demonstrated that EspI binds a
number of PDZ-containing proteins, including NHERF1
and NHERF2 (Lee et al., 2008).
NHERF proteins (NHERF1 to 4) are present in abun-
dance in the mammalian small intestine and colon (Donow-
itz et al., 2005) where they have a central role in trafficking,
membrane retention, dimerization and regulation of ion
channels and membrane proteins (Shenolikar and
Weinman, 2001; Shenolikar et al., 2004). NHERF1 and 2
are closely related (51% amino acid identity) and the only
members in the NHERF protein family which possess two
PDZ domains and a C-terminal ezrin/radixin/moesin
(ERM) binding domain (EBD) (Reczek et al., 1997; Yun
et al., 1998). The EBD domain links NHERF1 and 2 to the
actin cytoskeleton thereby forming a scaffold for highly
organized multimeric signalling complexes (reviewed in
Lamprecht and Seidler, 2006). More than 30 binding part-
ners have been reported for NHERF1 and 2 (Shenolikar
et al., 2004), some are shared by more than one NHERF
isoform (Yun et al., 1998; Sun et al., 2000), while others
are NHERF isoform-specific (Shenolikar et al., 2004).
In this paper we report the binding of three T3SS effec-
tor proteins (Map, EspI and NleH1) to a single eukaryotic
target (NHERF2). We show that NHERF2 influences the
trafficking and function of EspI, Map and NleH1, suggest-
ing that it functions as a distribution hub at the plasma
membrane.
Results
Map, EspI and NleH1 bind NHERF2
Previous reports have demonstrated that Map interacts
with NHERF1 (Alto et al., 2006; Simpson et al., 2006), and
a global PDZ array screen indicated that EspI might bind
NHERF1 and NHERF2 (Lee et al., 2008). In this study we
screened target proteins, which are recognized by the
PDZ-motifs of Map and NleH1 using the PDZ array. Over-
laying a fusion consisting of the last 50 amino acids of Map
and GST (GST-MapC50) on the PDZ-domain array con-
firmed that Map binds PDZ1 of NHERF1 (Fig. 1A). In
addition, we found that Map interacted with PDZ2 of
NHERF1 and both PDZ domains of NHERF2 (Fig. 1A).
NHERF2 was also identified as interaction partner of Map
by a yeast two-hybrid screen using full-length Map as bait
and HeLa cDNA library as a prey (data not shown). Over-
laying a fusion consisting of the last 150 amino acids of
NleH1 and GST (GST-NleH1C150) (a GST-NleH1C50
fusion was unstable) on the PDZ-domain protein array
revealed that NleH1 bound PDZ2 of NHERF2, although
this interaction appeared weaker than either Map:NHERF2
or EspI:NHERF2 (Fig. 1A) (Lee et al., 2008).
In order to confirm and characterize the interaction of
Map, EspI and NleH1 with NHERF2, we constructed and
purified His-NHERF2 and MBP fusions of NHERF2 PDZ1,
PDZ2 and EBD, which were immobilized on a membrane
and overlaid with purified MBP-Map, His-EspI and GST-
NleH1. Detection of bound proteins with effector-specific
antiserum revealed that Map, EspI and NleH1 interacted
with full-length NHERF2 (Fig. 1B). Map and EspI, but not
NleH1, also bound the purified PDZ2 domain of NHERF2
(Fig. 1B). Although Map interacted with PDZ1 of NHERF2
on the PDZ array, neither Map nor EspI bound the purified
PDZ1 or EBD domains (Fig. 1B). These results show that
despite some differences between binding to the arrayed
and fusion proteins, NHERF2 is targeted by Map, EspI and
NleH1.
In a reciprocal experiment full-length Map, EspI and
NleH1 were overlaid with His-NHERF2, which confirmed
the interactions (Fig. 1C, D and E). This binding was
dependent on the PDZ-binding motifs of Map and EspI as
NHERF2 did not bind the C-terminally truncated effectors
MapDC3 (Fig. 1C) or EspIDC7 (Fig. 1D). Unfortunately,
due to protein instability of NleH1DC4, the role of the PDZ
binding motif of recombinant NleH1 in binding NHERF2
could not be investigated.
NHERF2 co-immunoprecipitates EspI and NleH1 and
colocalizes with Map, EspI and NleH1
Once we confirmed the interaction between NHERF2
and Map, EspI and NleH1 using recombinant proteins,
we aimed to confirm the interaction by coimmunoprecipi-
tation. Towards this end we generated a stable HeLa
cell line constitutively expressing HA-tagged NHERF2
(HeLa–NHERF2). Immunofluorescence microscopy
using anti-HA antibodies revealed that NHERF2 local-
ized mainly at the plasma membrane (data not shown),
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in a pattern similar to that reported in un-polarized epi-
thelial cells like A431 or HT1080 cells, which express
NHERF2 endogenously (Theisen et al., 2007). The
HeLa–NHERF2 cells were infected for 1 h with EPEC
Dmap and EPEC Dmap expressing full-length Map or
MapDC3; EPEC DespI and EPEC DespI expressing full-
length EspI or EspIDC7; and EPEC DnleH and EPEC
DnleH expressing full-length NleH1 or NleH1DC4. We
were unable to co-immunoprecipitate NHERF2 and full-
length Map or MapDC3 (data not shown). Probing
infected cell extracts with anti-EspI and anti NleH1
revealed that while both full-length EspI and EspIDC7
were found in equal amounts, NleH1DC4 was unstable
(Fig. 2A and B). Following cell lysis the supernatants
were subjected to co-immunoprecipitation with anti-HA
antibodies. While NHERF2 did not co-immunoprecipitate
EspIDC7 (Fig. 2A) and NleH1DC4 (Fig. 2B), both full-
length EspI (Fig. 2A) and NleH1 (Fig. 2B) were
co-immunoprecipitated.
In order to determine if the effectors colocalize with
NHERF2, HeLa–NHERF2 cells were transfected with
pRK5 (Fig. 3) or pRK5 expressing myc-tagged Map,
MapDC3, NleH1 and NleH1DC4 as well as pGFP-EspI
and pGFP-EspIDC7. Analysing the transfected cells by
immunofluorescence revealed that Map colocalized with
mitochondria (Fig. S1) and NHERF2 (Fig. 3). Plasma
membrane-associated EspI and NleH1 colocalized
with NHERF2 (Fig. 3). We observed no colocalization
of NHERF2 and MapDC3, EspIDC7 or NleH1DC4
(Fig. S2).
Fig. 1. A. PDZ-domain protein arrays were overlaid with purified GST-MapC50, GST-NleH1C150 or GST followed by detection with anti-GST
antibodies. MapC50 interacts with PDZ1 and 2 domains of NHERF1 and NHERF2 whereas NleH1C150 interacts only with the PDZ2 domain
of NHERF2.
B. Purified His-NHERF2, MBP-PDZ1, MBP-PDZ2, MBP-EBD and MBP were transferred onto PVDF membrane and overlaid with purified
MBP-Map followed by detection with anti-Map, His-EspI followed by detection with anti-EspI or GST-NleH1 followed by detection with
anti-NleH. Equivalent protein loading was confirmed by Coomassie staining. Map, EspI and NleH1 interact with His-NHERF2, but only Map
and EspI interacted with MBP-PDZ2 (black arrows).
C and D. Bacterial extracts of EPEC Dmap overexpressing Map and MapDC3 (C) or EPEC DespI overexpressing EspI and EspIDC7 (D) were
transferred onto PVDF membrane and overlaid with purified His-NHERF2 followed by detection with anti-NHERF2 or immunoblotted with an
anti-Map or anti-EspI antibody. NHERF2 was able to interact with Map and EspI but not MapDC3 or EspIDC7.
E. Purified His-NHERF2, GST, GST-NleH1 and His-EspI were transferred onto PVDF membrane and overlaid with purified His-NHERF2
followed by detection with anti-NHERF2 or immunoblotted with anti-GST. NHERF2 interacted with His-EspI and GST-NleH1 (black arrow).
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Fig. 2. A. HA-NHERF2 was immunoprecipitated with anti-HA from HeLa–NHERF2 cells infected for 1 h with the indicated EPEC strains.
Equivalent protein loading was confirmed by anti-NHERF2 Western blots. Anti-EspI Western blot reveals equivalent levels of EspI and
EspIDC7 in the whole-cell extract and the presence of EspI, but not EspIDC7, in HA-NHERF2 immunoprecipitated sample.
B. HA-NHERF2 was immunoprecipitated with anti-HA from HeLa–NHERF2 cells infected for 1 h with the indicated EPEC strains. Equivalent
loading of proteins was monitored by anti-NHERF2 Western blots. Anti-NleH1 Western blot reveals presence of NleH1 in whole-cell extracts
(left panel), which was immunoprecipitated with HA-NHERF2 sample (right panel).
Fig. 3. Fluorescence microscopy of
HeLa–NHERF2 cells transfected with pRK5
(Mock), pRK5-map (Map), pEGFP-C2-espI
(EspI) and pRK5-nleH1 (NleH1). NHERF2
was detected with anti-HA (green) and
effectors Map and NleH1 were stained with
anti-myc (red). Green GFP signal was
converted to red for EspI. Map colocalizes
with NHERF2 (open arrows), while partial
colocalizations of EspI and NleH1 with
NHERF2 are observed at the plasma
membrane (plain arrows). Scale bar = 10 mm.
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NHERF2 modulates Map-induced filopodia dynamics
We investigated the effect of NHERF2 expression on
Map-induced filopodia. First, HeLa and HeLa–NHERF2
were transfected with pRK5 expressing myc-tagged
Map or MapDC3 and examined by scanning electron
microscopy. This revealed that ectopic expression of Map
resulted in filopodia formation in both cell lines, although
the length and complexity of filopodia were more promi-
nent on the HeLa–NHERF2 cells (Fig. 4A). Relatively
small and sporadic filopodia were observed in either cell
line ectopically expressing MapDC3 (Fig. 4A). Next HeLa
and HeLa–NHERF2 cells were infected with EPEC
wild-type and the dynamics of filopodia formation and
withdrawal was quantified by counting infected cells with
filopodia over time. This revealed that at each time point
more HeLa–NHERF2 cells with filopodia were observed
compared with HeLa cells (Fig. 4B).
To investigate whether persistence of filopodia was
due to the PDZ-mediated Map–NHERF2 interaction, the
number of cells with filopodia was quantified following
infection of HeLa and HeLa–NHERF2 cells with EPEC
Dmap expressing Map or MapDC3. Upon infection with
EPEC Dmap expressing full-length Map, the fraction of
infected HeLa–NHERF2 cells with filopodia was higher
and decreased much slower compared with infected
HeLa cells (Fig. 4C). This is consistent with the pheno-
type observed for infection with wild-type EPEC
(Fig. 4B). In contrast, no difference in numbers of cells
with filopodia or the kinetics of filopodia withdrawal was
found between HeLa–NHERF2 and HeLa cells infected
with EPEC Dmap expressing MapDC3 (Fig. 4C). These
results suggest that the expression of NHERF2 in HeLa
cells modulates Map-induced filopodia formation and
persistence, which is dependent on the PDZ-mediated
Map–NHERF2 interaction.
NHERF2 accelerates trafficking of EspI to the Golgi
During the early stages of EPEC infection, localization of
EspI shifts from the site of bacterial adhesion to the
Golgi apparatus, and this trafficking is enhanced by its
PDZ binding motif (Lee et al., 2008). In order to inves-
tigate the possible role of NHERF2 in trafficking of EspI
to the Golgi, HeLa and HeLa–NHERF2 cells were
infected for 15, 30, 60 and 90 min with EPEC DespI
expressing EspI. The number of infected cells with EspI
colocalizing with the Golgi protein GM130 was quantified
by immunofluorescence microscopy (Fig. 5A). At 15 and
30 min post infection, significantly more HeLa–NHERF2
cells showed EspI staining at the Golgi apparatus com-
pared with HeLa cells (Fig. 5A). To determine the impor-
tance of the EspI–NHERF2 interaction for trafficking of
the protein to the Golgi apparatus, HeLa–NHERF2 cells
were infected for 15, 30, 60 and 90 min with EPEC
DespI expressing EspI or EspIDC7 (Fig. 5A). Golgi
staining of EspIDC7 was significantly lower after 30
(Fig. 5A and B), 60 and 90 min post infection compared
with cells infected with EPEC DespI expressing EspI
(Fig. 5A).
Taken together, these results suggest that following
translocation EspI interacts with NHERF2 via its PDZ-
binding motif, which accelerates trafficking of EspI to the
Golgi apparatus.
NHERF2 antagonises the anti-apoptotic activity
of NleH1
NleH1 interacts with Bax inhibitor-1, which protects the
cell against various apoptotic stimuli (Hemrajani et al.,
2010; Robinson et al., 2010). We investigated the impact
of NHERF2 expression on the anti-apoptotic activity of
NleH1. Low translocation levels of NleH1DC4 prevented
an analysis of the importance of the PDZ-binding motif
during infection. To circumvent this, we ectopically
expressed NleH1 and NleH1DC4 in HeLa or HeLa
NHERF2 cells, which were treated with the pro-apoptotic
compound staurosporine (STS). The number of trans-
fected apoptotic cells, marked by caspase-3 activation or
nuclear condensation, was quantified by immunofluores-
cence counting. Significantly fewer HeLa cells trans-
fected with pRK5-NleH1 displayed caspase-3 activation
(Fig. 6A and B) or nuclear condensation (Fig. 6C) com-
pared with pRK5-transfected HeLa cells or cells trans-
fected with pRK5-NleH1DC4. Mock-transfected HeLa–
NHERF2 cells displayed a similar phenotype as normal
HeLa cells, showing that NHERF2 expression per se
neither promotes nor prevents STS-induced apoptosis
(Fig. 6B and C). Expression of NHERF2 did not influ-
ence the phenotype of cells expressing NleH1DC4.
However, the inhibition of caspase-3 cleavage (Fig. 6A
and B) and nuclear condensation (Fig. 6C) by NleH1
was significantly abolished in cells expressing
HA-NHERF2 compared with the HeLa cell control. Taken
together, these results show that even though the anti-
apoptotic activity of NleH1 depends on its PDZ-binding
motif, the interaction with NHERF2 is not the trigger for
its anti-apoptotic signalling. The data rather suggest that
NHERF2 counteracts the anti-apoptotic activity of
NleH1, possibly by direct competition for its PDZ binding
site or interference with its intracellular trafficking and
localization.
Discussion
NHERF proteins are known to orchestrate intracellular
protein trafficking, protein localization and cell signalling;
regulation of ion transporters being the best-studied
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example. NHERFs, which are modular proteins compris-
ing several protein–protein interaction domains, function
as scaffolds for the assembly of multiprotein complexes
at the plasma membrane. In particular, NHERFs are
involved in tethering plasma membrane localized trans-
porters such as NHE3, the apical form of the Na+/H+
exchanger and CFTR, a cAMP-regulated Cl-channel, to
the underlying actin cytoskeleton. NHERF1 and 2 bind the
Fig. 4. A. Scanning electron microscopy of Hela and HeLa–NHERF2 cells transfected with pRK5 (Mock), pRK5-map or pRK5-mapDC3.
Transfection of cells with pRK5-map induced filopodia in both cell lines; however, filopodia formed on HeLa–NHERF2 were longer and more
complex. Only sparse filopodia formation was observed upon transfection with pRK5-mapDC3. Scale bar = 10 mm.
B. Quantification of infected HeLa (black bars) and HeLa–NHERF2 (white bars) cells displaying filopodia following infection with wild-type
EPEC. Downregulation of filopodia is delayed in HeLa cells expressing HA-NHERF2. One hundred infected cells were counted in three
independent experiments. Results are shown as mean  SD. P-values of < 0.05 (*) were considered as significant.
C. Quantification of infected HeLa and HeLa–NHERF2 cells displaying filopodia following infection with EPEC Dmap overexpressing Map or
MapDC3. EPEC Dmap overexpressing Map, but not MapDC3, maintains filopodia over time in HeLa–NHERF2 cells compared with HeLa cells.
One hundred infected cells were counted in three independent experiments. Results are shown as mean  SD. P-values of < 0.05 (# for Map
versus MapDC3 in HeLa cells, § for Map versus MapDC3 in HeLa–NHERF2 cells) were considered as significant.
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transporters via their PDZ domains and actin-associated
ERM proteins via their C-terminal EBD (Brone and Egg-
ermont, 2005), thus linking the actin cytoskeleton to the
plasma membrane (Bretscher et al., 2000). The assign-
ment of individual functions to NHERF1 or 2 has proven to
be difficult due to high homology and widely overlapping
interactomes. Localization studies have shown that, in
polarized Caco-2 cells, NHERF1 is predominantly found
in the brush border (BB) whereas NHERF2 has some BB
localization but is mainly found in the inter-microvillar
clefts below the BB (Donowitz et al., 2005). The differen-
tial subcellular localization and tissue distribution of
NHERFs might determine functional specificity and
account for the observation from studies with knockout
mice that NHERF1–3 are not functionally redundant.
(Seidler et al., 2009). Despite their central position in
diverse signalling processes, the role of NHERF proteins
as versatile targets for bacterial effector proteins has not
been fully investigated.
Although fulfilling unrelated intracellular functions Map,
EspI and NleH1 share two common post-translocation
features, binding to NHERF2 and trafficking to an intrac-
ellular membranous compartment. Map is targeted to the
mitochondria (Kenny and Jepson, 2000), EspI to the Golgi
(Gruenheid et al., 2004) and NleH1 to the endoplasmic
reticulum (ER) (Hemrajani et al., 2010). A PDZ array
screen indicated that Map, EspI and NleH1 bind NHERF2.
Using recombinant Map, EspI and NleH1 and a stable
NHERF2 cell line revealed that all three effectors interact,
in a PDZ binding motif-dependent manner, with NHERF2.
Moreover, all three effectors colocalized with NHERF2
in HeLa–NHERF2 cells, and EspI and NleH1 were
co-immunoprecipitated with NHERF2 from infected cells.
Our efforts to co-immunoprecipitate Map and NHERF2
Fig. 5. A. Quantification of EspI Golgi
localization in HeLa and HeLa–NHERF2 cells
infected with EPEC DespI expressing EspI
or EspIDC7. Increased EspI localization at
the Golgi apparatus was observed in
HeLa–NHERF2 cells compared with HeLa
cells following 15 and 30 min of infection (*).
EspIDC7 shows reduced localization to the
Golgi compared with EspI in both cell lines
(# for HeLa cells, § for HeLa–NHERF2 cells).
Fifty infected cells were counted in three
independent experiments. Results are shown
as mean  SD. P-values of < 0.05 (* for HeLa
versus HeLa–NHERF2 in EPEC DespI
overexpressing EspI infected cells, # for EspI
versus EspIDC7 in HeLa cells and § for EspI
versus EspIDC7 in HeLa–NHERF2 cells) were
considered as significant.
B. Fluorescence microscopy of
HeLa–NHERF2 infected for 30 min with EPEC
DespI and EPEC DespI expressing EspI or
EspIDC7. EspI was stained with anti-EspI
(red), Golgi apparatus was stained with
anti-GM130 (green) and DNA was
counterstained with Hoechst 33342 (cyan).
EspI is detected at the bacterial attachment
sites (open arrows); however, Reduced
colocalization with the Golgi was observed for
cells infected with EPEC DespI expressing
EspIDC7 (plain arrows). Scale bar = 10 mm.
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were not successful. The fact that expression of NHERF2
in HeLa cells modulated the intracellular trafficking and/or
activity of all three effectors suggests that NHERF2 might
form a molecular hub at the plasma membrane from which
the effectors are distributed to their final destinations.
Map acts as a Rho-guanine nucleotide exchange factor
(GEF) for Cdc42 (Huang et al., 2009), but is unique in the
family of WxxxE motif proteins in possessing a PDZ-
binding motif at the C-terminus (Alto et al., 2006; Bulgin
et al., 2010). Approximately 37% of human and mouse
GEFs also possess a PDZ binding motif and there is
increasing evidence that PDZ-based interactions are
important for GEF function, and aid targeting of the GEF
to a subcellular location (Garcia-Mata and Burridge,
2007). Here removal of the C-terminal PDZ motif
abolished the interaction of Map with NHERF2 and led to
Fig. 6. A. Fluorescence microscopy of HeLa and HeLa–NHERF2 cells transfected with pRK5 or pRK5-nleH1 and treated for 4 h with 1 mM
STS. HA-NHERF2 was stained with anti-HA (red), NleH1 with anti-myc (green) and activated caspase-3 was detected with anti-cleaved
caspase-3 (white). Expression of NleH1 in HeLa cells inhibited activation of caspase-3 whereas expression of NleH1 in HeLa–NHERF2 cells
did not. Scale bar = 10 mm.
B and C. HeLa and HeLa–NHERF2 cells were transfected with pRK5 (black bars), pRK5-nleH1 (white bars) or pRK5-nleH1DC4 (grey bars)
before treated with 1 mM STS for 4 h. Capsase-3 activation and nuclear condensation in transfected cells were observed by
immunofluorescence microscopy using anti-myc, anti-cleaved caspase-3 (B) and Hoechst 33342 DNA staining (C). Immunofluorescence
analysis revealed that cells expressing HA-NHERF2 and NleH1 were more often positive for caspase-3 activation and nuclear condensation
than HeLa cells expressing NleH1. One hundred transfected cells were counted for activated caspase-3 or nuclear condensation in three
independent experiments. Results are shown as mean  SD. P-values of < 0.05 (*) were considered as significant.
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reduced filopodia formation and stability. Endogenous
GTPases are modified posttranscriptionally by the addi-
tion of a lipid moiety to the C-terminus (farnesyl, geranyl,
palmitoyl or methyl) (Roberts et al., 2008), which targets
them to different membranous compartments. We
suggest that the interaction of Map with the PDZ2 domain
of NHERF2 may transiently anchor Map at the apical
surface of an infected cell leading to filopodia formation
beneath adherent bacteria, before the effector is targeted
to the mitochondria.
EspI has been reported to inhibit COPII-dependent
vesicular transport between the ER and Golgi leading to
alterations in host cell protein secretion and tight junction
integrity (Kim et al., 2007; Thanabalasuriar et al., 2010).
EspI dynamics and trafficking upon translocation are still
poorly understood since the protein accumulates at the
Golgi apparatus and not at the ER, where COPII vesicles
are formed (Kim et al., 2007). Here we showed that the
interaction between EspI and NHERF2 is mediated
through the EspI C-terminal PDZ-binding motif, resulting in
an increased rate of trafficking of EspI to the Golgi. This
result is consistent with the potential role of NHERF2 in
recycling of endogenous membrane proteins (Donowitz
et al., 2005).
Recently, we found that NleH1 inhibits cell apoptosis
by interacting with Bax inhibitor-1 and decreasing acti-
vation of caspase-3, nuclear condensation and mito-
chondrial hyper permeabilization (Hemrajani et al., 2010;
Robinson et al., 2010). NleH1 also binds to ribosomal
protein 3 and reduces nuclear activity of NF-kB (Gao
et al., 2009). Similar to Map and EspI, we found that
NleH1 possesses a class I PDZ binding motif that regu-
lates its anti-apoptotic function. Although a recombinant
PDZ-binding motif mutant form of NleH1 could not be
purified because of protein instability, immunofluores-
cence of cells transfected with the PDZ motif mutant
demonstrated that the motif was critical to wild-type
function of NleH1 and its interaction with NHERF2.
However, the interaction with NHERF2 is not the trigger
for NleH1-mediated anti-apoptotic signalling; on the con-
trary, binding of NleH1 to NHERF2 inhibits anti-apoptotic
activity. This might represent a mechanism for the tem-
poral control of NleH1 anti-apoptotic function. In addi-
tion, NleH1-NHERF2 interaction might enable NleH1 in
general, or a fraction of the translocated protein, to
perform a secondary, yet unidentified, activity before or
in parallel to promoting cell survival.
The fact that three different T3SS effectors, which share
little sequence similarity and have distinct functions, bind
a single host cell scaffold protein is unprecedented. More-
over, while NleH1 binds NHERF2 only, EspI and Map bind
both NHERF1 and NHERF2. It is tempting to speculate
that EPEC and EHEC exploit endogenous BB-associated
NHERFs to regulate spatial and temporal intracellular traf-
ficking of Map, EspI and NleH1. Indeed, during infection of
mice with wild-type C. rodentium NHERF2 was exten-
sively recruited to the bacterial attachment sites (data not
shown).
T3SS effectors function in a co-ordinated manner. As
effectors from a single pathogen can complement or
antagonize each other, the timing and location of their
activity must be highly regulated. While timing of gene
expression and effector protein translocation provides a
regulatory mechanism at the bacterial level (Mills et al.,
2008), ubiquitination followed by proteasomal degrada-
tion (Kubori and Galan, 2003) and protein phosphoryla-
tion (Kenny, 1999) represent mechanisms, which are
exploited to control the activity of translocated effectors
within host cells. In this study we identified a novel regu-
latory mechanism by which recruitment of NHERFs to
the bacterial attachment site forms a distribution hub,
which is exploited for membrane retention (Map) or traf-
ficking (EspI). We propose that differential binding to
NHERF1 and/or NHERF2 and to their different PDZ
domains provides a mechanism to fine tune the activity
of the hub. We aim to exploit the C. rodentium model to
test this hypothesis in the context of host pathogen inter-
actions in vivo.
Experimental procedures
Bacterial strains and growth conditions
Escherichia coli strains used in this study are listed in Table 1.
Bacteria were cultured in Luria-Bertani (LB) medium or in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with ampicillin (100 mg ml-1) or kanamycin (50 mg ml-1) as
appropriate.
Plasmids
Plasmids and primers used in this study are listed in Tables 2 and
3. For cloning into the bacterial expression vector pSA10
(Schlosser-Silverman et al., 2000), espI, espIDC7 and nleH1DC4
were amplified from EPEC genomic DNA using primer pairs
EspI-Fw1 and EspI-Rv1, EspIDC7-Rv1 and NleH1-Fw1 and
NleH1DC4-Rv, respectively. For generation of (His)6-tagged pro-
teins, nherf2 was amplified from pBKCMV-HA-NHERF2 using
primers NHERF2-Fw and NHERF2-Rv and espI was amplified
from EPEC genomic DNA using primers EspI-Fw2 and EspI-Rv2;
both PCR products were cloned into pET28a(+) (Novagen). For
Table 1. List of strains.
Strain Description Origin
E2348/69 Wild-type EPEC O127:H6 Levine et al. (1978)
ICC202 E2348/69 Dmap Simpson et al. (2006)
ICC248 E2348/69 DespI Marches et al. (2008)
ICC303 E2348/69 DnleH1DnleH2
(named DnleH)
Hemrajani et al. (2010)
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Table 2. List of plasmids.
Description Origin
pBKCMV Mammalian expression vector Stratagene
pBKCMV-HA-NHERF2 pBKCMV encoding HA-tagged NHERF2 Dr R. Hall
pSA10 pKK177-3 containing lacI Schlosser-Silverman et al. (2000)
pRK5 N-terminal Myc-tag mammalian expression vector Clontech
pICC330 pSA10-map Simpson et al. (2006)
pICC331 pSA10-mapDC3 Simpson et al. (2006)
pICC507 pSA10-espI This study
pICC508 pSA10-espIDC7 This study
pICC443 pSA10-nleH1 Hemrajani et al. (2010)
pICC535 pSA10-nleH1DC4 This study
pICC509 pRK5-map, encoding myc-tagged Map This study
pICC510 pRK5-mapDC3, encoding myc-tagged MapDC3 This study
pICC512 pRK5-nleH1, encoding myc-tagged NleH1 This study
pICC513 pRK5-nleH1DC4, encoding myc-tagged NleH1DC4 This study
pEGFP-C2 Vector expressing fusions to the C-terminus of GFP Clontech
pGFP-EspI pEGFP-C2-espI encoding EspI This study
pGFP-EspI DC7 pEGFP-C2-espIDC7 encoding EspIDC7 This study
pET28a His6-tag expression vector Novagen
pICC332 pET28a-nherf1, encoding His6-NHERF1 Simpson et al. (2006)
pICC514 pET28a-nherf2, encoding His6-NHERF2 This study
pICC515 pET28a-espI, encoding His6-EspI This study
pMalc2X MBP-tag expression vector New England Biolabs
pICC516 pMalc2X-map, encoding MBP-Map This study
pICC517 pMalc2X-PDZ1, encoding MBP-PDZ1 of NHERF2 This study
pICC518 pMalc2X-PDZ2, encoding MBP-PDZ2 of NHERF2 This study
pICC519 pMalc2X-EBD, encoding MBP-EBD of NHERF2 This study
pGEX-KG GST-tag expression vector GE Healthcare
pGEX-3X GST-tag expression vector GE Healthcare
pICC520 pGEX-KG-nleH1, encoding GST-NleH1 This study
pICC521 pGEX-KG-nleH1C150, encoding GST-NleH1c150 This study
pGST-Map50 pGEX-3X-mapC50, encoding GST-MapC50 This study
Table 3. List of primers (restriction sites in
bold).Name Sequence
NHERF2-Fw 5′-CTTAAAGCTAGCATGGCCGCGCCGGAG-3′
NHERF2-Rv 5′-GGGTTTGAATTCTCAGAAGTTGCTGAAG-3′
PDZ1-Fw 5′-CCGGAATTCCTGTGCCGCTTGGTGCGCG-3′
PDZ1-Rv 5′-ATTTCTGCAGTCACTGGTCCACCACCAGCAGCCGAG-3′
PDZ2-Fw 5′-CCGGAATTCCGGCTCTGCCACCTGCGAAAG-3′
PDZ2-Rv 5′-ATTTCTGCAGTCAGGGGTCCACGACCAGCAGCCGGG-3′
EBD-Fw 5′-CGGAATTCGAGACAGATGAACACTTCAAGCGGCTTC-3′
EBD-Rv 5′-GTTAAACTGCAGTCAGAAGTTGCTGAAGATTTC-3′
Map-Fw1 5′-TTTGAATTCGGAGCAAATGTTTAGTCCAACGGCAAT -3′
Map-Fw2 5′-TTTGAATTCGGAGCAATGTTTAGTCCAACGGCAAT -3′
Map-Rv 5′-CCAATGCATTGGTTCTGCAGCTACAGCCGAGTATCCTGCA-3′
MapDC3-Fw 5′-TAGCTGCAGAAGCTTGGCCG-3′
MapDC3-Rv 5′-ATCCTGCACATTGTCTGCAATC-3′
MapC50-Fw 5′-GGATCCCCGATCCCATTACACGTTTTAAC-3′
MapC50-Rv 5′-GAATTCCTACAGCCGAGTATCCTGCAC-3′
EspI-Fw1 5′-GGAATTCATGAACATTCAACCGATCGTAACATCCGG-3′
EspI-Fw2 5′-GGGGATCCAACATTCAACCGATCGTAACATCC-3′
EspI-Fw3 5′-CGGAATTCATGAACATTCAACCGATCG-3′
EspI-Rv1 5′-AGGGCCCGGGTTAGACTCTTGTTTCTTGGATTATATCAACGG-3′
EspI-Rv2 5′-CGGAATTCTTAGACTCTTGTTTCTTGGATTATATC-3′
EspI-Rv3 5′-CGGGATCCTTAGACTCTTGTTTCTTGG-3′
EspIDC7-Rv1 5′-AGGGCCCGGGTTAATCAACGGTATCAACATAATTTGATGG-3′
EspIDC7-Rv3 5′-CGGGATCCTTAATCAACGGTATCAACATAATTTGATGG-3′
NleH1-Fw1 5′-GCGGATCCGCGCTATCACCATCTTCTGTAAATTTG-3′
NleH1-Rv1 5′-GCGAAGCTTCTAAATTTTACTTAATACCACAC-3′
NleH1DC4-Rv 5′-CTGCAGTTTCGACTATACCACACTAATAAGATCTTG-3′
NleH1-Fw2 5′-GACTCCATGGGTCTATCACCATCTTCTGTAAATTTG-3′
NleH1c150-Fw 5′-GACTCCATGGGTTATGTTATTGGCAAAGGGGGTA-3′
NleH1-Rv2 5′-GCGAAGCTTCTAAATTTTACTTAATACCACAC-3′
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generation of MBP fusion proteins, map was amplified from
pICC330 using primer pair Map-Fw2 and Map-Rv2, and PDZ1,
PDZ2 and the ezrin-binding domain (EBD) of NHERF2 were
PCR-amplified from pBKCMV-HA-NHERF2 using primer pairs
PDZ1-Fw and PDZ1-Rv, PDZ2-Fw and PDZ2-Rv, EBD-Fw and
EBD-Rv; all constructs were cloned into pMalc2X (New England
Biolabs). For generation of GST fusion proteins, nleH1 and
nleH1C150 (encoding the 150 C-terminal amino acids of NleH1)
were amplified from EPEC genomic DNA using primer pairs
NleH1-Fw2 or NleH1C150-Fw and NleH1-Rv2 respectively. Both
constructs were cloned into pGEX-KG. For mapC50, the region
encoding the 50 C-terminal amino acids of Map was amplified
from EPEC genomic DNA using primer pairs MapC50-Fw or
MapC50-Rv. The resulting fragment was cloned into the SmaI/
EcoRI sites of pGEX-3X. For transfection experiments, map,
nleH1 and nleH1DC4 were amplified from EPEC genomic DNA
using primer pairs Map-Fw1 and -Rv1, NleH1-Fw1 and NleH1-
Rv1 or NleH1DC4-Rv, respectively, and cloned into pRK5.
Plasmid pRK5-MapDC3 was generated by inverse PCR using
pRK5-Map as template. espI and espIDC7 were amplified from
EPEC genomic DNA using primer pairs EspI-Fw3 and EspI-Rv3
or EspIDC7-Rv3, respectively, and cloned into pGFP-C2. All con-
structs were verified by DNA sequencing.
Protein expression and purification
Genes cloned into pET28a, pMALc2X and pGEX vectors were
expressed in E. coli BL-21/DE3 star strain (Invitrogen) in pres-
ence of 1 mM isopropyl-b-D-thiogalactopyranoside (IPTG) at
37°C as described previously (Crepin et al., 2005). His-tagged
proteins were purified using Ni2+ agarose His-Bind Resin Column
(Novagen), MBP-tagged proteins were purified on Amylose resin
(New England Biolabs) and GST-tagged proteins were purified
on glutathione-sepharose (GE Healthcare) using manufacturer’s
recommendations.
PDZ array screen
To assess the binding of the GST-MapC50 and NleH1C150
fusion proteins to the PDZ domain array, purified His-tagged PDZ
domain fusion proteins were spotted as previously described
(Fam et al., 2005; He et al., 2006) at 1 mg per bin onto Nytran
SuperCharge 96-grid nylon membranes (Schleicher & Schuell).
The membranes were allowed to dry overnight and then blocked
in ‘blot buffer’ (2% non-fat dry milk, 0.1% Tween-20, 50 mM NaCl,
10 mM Hepes, pH 7.4) for 30 min at room temperature. The
arrays were then overlaid with control GST, GST-MapC50 or
GST-NleH1C150 fusion proteins (100 nM in blot buffer) overnight
at 4°C. The overlaid arrays were washed three times for five
minutes each with 20 ml blot buffer, incubated with anti-GST
horseradish peroxidase (HRP)-conjugated antibody (Amersham,
1:4000) for 1 h at room temperature, washed again three times
for 5 min each with 20 ml blot buffer, and ultimately visualized via
chemiluminescence with the ECL kit from Pierce.
Yeast two-hybrid
Yeast two-hybrid screen using Map as prey and cDNA library as
bait was performed as described before (Simpson et al., 2006).
Western and far Western blot
Far Western blot was performed using 10 mg ml-1 of His-
NHERF2, His-EspI, MBP-Map or GST-NleH1 in Tris buffered
saline (TBS) 0.1% Tween20 with 1% skimmed milk followed by
Western blot detection as previously described (Simpson et al.,
2006). Western blots were performed following standard
methods using rabbit anti-NHERF2 (raised against purified
human His-NHERF2, Covalab), anti-EspI (Lee et al., 2008), anti-
NleH (raised against purified His-NleH1, Covalab), mouse anti-
Map (Immune Systems limited), anti-poly-Histidine (Sigma),
anti-GST (AbCam) and anti-HA HRP-conjugated (Roche) anti-
bodies. Goat anti-mouse and anti-rabbit IgG HRP conjugates
(Jackson laboratories) were used as secondary antibodies.
Transfection and generation of NHERF2 stable cell line
HeLa cells were routinely maintained in DMEM containing 10%
fetal calf serum (FCS) and 1 mM L-glutamine (Gibco) in a humidi-
fied atmosphere of 5% CO2 at 37°C. Transfection with pBKCMV,
pRK5 and pEGFP vectors and their derivatives was performed
using lipofectamin 2000 (Invitrogen) according to the manufac-
turer’s recommendations.
To generate the stable cell line, HeLa cells were grown to
confluence in 75-cm2 cell culture flasks and transfected with
pBKCMV-HA-NHERF2 using lipofectamin 2000 (Invitrogen) as
previously described (Oh et al., 2004). After 16 h, cells were
trypsinized and 2 ¥ 105 cells were sub-cultured in 100 mm Petri
dishes in DMEM media supplemented with 800 mg ml-1 geneticin
(Invitrogen). Cells were cultured for 10 days in the same Petri
dish with repeated change of media for selection of resistant
clones. Single clones were transferred to 96-well plates
(Nalgene) and grown to confluence. Clones were then trans-
ferred to 24-well plates and replicate 24-well plates containing
coverslips for expression analysis by immunofluorescence
microscopy. Positive clones were trypsinized, sub-cultured in
25 cm2 flasks and then stored at -80°C in DMEM supplemented
with 10% dimethylsulfoxide (DMSO). In this article, the stable cell
line is referred as HeLa–NHERF2.
Infection of HeLa cells
Cells were seeded onto glass coverslips 48 h prior to infection at
a 70% confluence and maintained in DMEM supplemented with
10% FCS at 37°C in 5% CO2. Three hours before infection, cells
were washed three times with PBS and the media replaced with
fresh DMEM without FCS. To prime bacteria for infection, DMEM
was inoculated with overnight cultures at a dilution of 1:50 of the
appropriate bacteria as previously described (Collington et al.,
1998). Recombinant protein expression was induced by addition
of 1 mM of IPTG 30 min prior to infection. Infections were carried
out at 37°C in 5% CO2 at a multiplicity of infection (MOI) of 100 for
each time point (15, 30, 60 or 90 min).
Co-Immunoprecipitation (Co-IP)
HeLa–NHERF2 cells were grown to confluence in 25 cm2 cell
culture flasks and infected for 1 h as described above. Cells were
washed 3 times with PBS and lysed in 500 ml of Co-IP buffer
[50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1% NP40, 0.5% sodium
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deoxycholate, 10% glycerol, protease inhibitors (Complete,
Roche)]. The lysate was transferred to a pre-chilled eppendorf
tube and centrifuged at 9200 g for 10 min at 4°C. The cleared
lysate was transferred to a fresh pre-chilled eppendorf tube con-
taining 15 ml of pre-equilibrated anti-HA agarose beads (Sigma)
and incubated on a spinning wheel for 2 h at 4°C. The suspension
was washed three times in Co-IP buffer followed by brief centrifu-
gation at 9200 g at 4°C after each wash. Bound proteins were
eluted using 80 ml of 100 mg ml-1 HA peptide (Sigma). Analysis of
the samples was performed by Western blot as described before.
Immunofluorescence staining and microscopy
Following infection or transfection, the coverslips were washed
three times in phosphate-buffered saline (PBS) and fixed with 3%
paraformaldehyde (PFA) for 20 min before being washed 3 more
times in PBS. The fixed cells were quenched for 20 min with PBS
50 mM NH4Cl, permeabilized for 4 min in PBS 0.25% Triton
X-100 and washed three times in PBS. The samples were
blocked for 1 h with PBS 5% bovine serum albumin (BSA) prior to
incubation with primary and secondary antibodies. The primary
mouse anti-HA (Covance) and anti-GM130 (BD transduction
laboratories) as well as rabbit anti-Myc (AbCam) and anti-cleaved
caspase-3 antibodies (Cell Signalling Technology) were used at a
dilution of 1:200. Rabbit anti-O127 (kindly provided by Dr Roberto
La Ragione, Veterinary Laboratory Agency, UK) was used at a
dilution of 1:500. The samples were incubated with the primary
antibody for 1 h, washed three times in PBS and incubated with
the secondary antibodies for 1 h. Donkey anti-rabbit IgG conju-
gated to a Cy3, Cy5 or AMCA fluorophore and donkey anti-
mouse IgG conjugated to Cy2, Cy3 or Cy5 fluorophores (Jackson
ImmunoResearch) were used at a 1:200 dilution. Mouse anti-Myc
FITC-conjugated antibody (Sigma) was used at a 1:100 dilution.
Actin was stained using Rhodamine phalloidin (Invitrogen) at a
1:500 dilution and DNA was stained using Hoechst 33342
(Molecular Probes). All dilutions were prepared in PBS containing
5% BSA. Following three washes in PBS, coverslips were
mounted on SuperFrost glass slides using Prolong Gold antifade
reagent (Invitrogen) and visualized with a Zeiss Axioimager
immunofluorescence microscope. All images were analysed
using the Axiovision Rel 4.5 software.
Apoptosis assay
For apoptosis studies, 1 mM staurosporine (STS) (Calbiochem)
was added to the media during 4 h and apoptotic cells (stained
either for nuclear condensation or caspase-3 activation) were
counted using immunofluorescence microscopy as described
(Hemrajani et al., 2010).
Scanning electron microscopy (SEM)
HeLa and HeLa–NHERF2 cells transfected with pRK5-Map or
pRK5-MapDC3 were washed three times with PBS and fixed with
3% glutaraldehyde in PBS. The samples were then washed with
PBS three times before being post fixed in 1% Osmium Tetroxide
for 1 h. Following three washes in PBS and 15 min dehydration in
graded ethanol solutions (50% to 100%), the samples were trans-
ferred to an Emitech K850 Critical Point drier and processed
according to the manufacturer’s instructions. The samples were
coated with gold/palladium using an Emitech Sc7620 minisputter
to a thickness of approximately 370 Å and examined at an
accelerating voltage of 20 kV using a Jeol JSM-6390 electronic
microscope.
Statistical analysis
Results are expressed as mean values  standard deviation. All
statistical tests were performed using the program Sigma Plot
version 11.0 using the parametric Student’s t-test. P < 0.05 was
considered as significant.
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Supporting information
Additional Supporting Information may be found in the online
version of this article:
Fig. S1. Fluorescence microscopy of HeLa–NHERF2 cells trans-
fected with pRK5 (Mock) and pRK5-map. Mitochondria were
detected with Mitotracker (red) and Map was detected with anti-
myc (green). Map colocalizes with the mitochondria. Scale
bar = 10 mm.
Fig. S2. Fluorescence microscopy of HeLa–NHERF2 cells trans-
fected with pRK5 (Mock), pRK5-mapDC3, pEGFP-C2-espIDC7
and pRK5-nleH1DC4. NHERF2 was detected with anti-HA
(green) and effectors Map and NleH1 were stained with anti-myc
(red). Green GFP signal was converted to red for EspI. Neither
effector colocalized with NHERF2. Scale bar = 10 mm.
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